The Honorable Rick ScottChairSpecial Committee on AgingUnited States SenateWashington, D.C. 20510 The Honorable Kirsten GillibrandRanking MemberSpecial Committee on AgingUnited States SenateWashington ...
SB161 would require that non-opioid pain treatments that have FDA approval be included on this preferred drug list with coverage terms that are no more restrictive than those given to opioid pain ...
Days afta di BBC Africa eye don publish di latest exposé about one pharmaceutical company for India wey don dey produce ...
Through the Arkansas Opioid Recovery Partnership, we have funded innovative programs aimed to slow the relentless increase in ...
Health care providers can now administer Sublocade subcutaneously into the thigh, buttock, or the back of the upper arm, in addition to the abdomen.
The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...
Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...
In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...
Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...
It’s time for Pennsylvania to update its standing health orders to allow for the use of all FDA-approved opioid overdose ...